Ayush services sector supports 1.76 million livelihoods; women constitute 43% of the workforce

The Ayush services sector supports 1.76 million livelihoods in India and has a significant female workforce. Women's participation in organized segments, including hospitals, exceeds 50 percent in several areas. The sector has the potential to expand substantially, generating an estimated USD 216-318 billion by 2047. Ayurveda remains the largest individual system of revenue generation within the sector, contributing significantly.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8vEpzIN
via IFTTT

Read More

The 30-Minute Medicine Problem

How India's largest ePharmacy is building an in-house quick-commerce engine across cities and why moving medicines in under an hour is far more complicated than it looks

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/c4NTo3D
via IFTTT

Read More

Drug panel rejects child images on cough syrup labels, proposes age warning for use below 4 years

Cough syrup bottles will soon include a prominent red warning stating their use is not recommended for children under four. An expert committee rejected child-oriented imagery on labels, which could imply suitability for young children. This decision follows ongoing concerns about the safety of cough syrups in pediatric care. The proposed change aims to prevent confusion regarding age restrictions for these medications.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BwgnLQy
via IFTTT

Read More

Lord’s Mark strengthens UK and UK allied market strategy with regulatory backing for IVD portfolio.

In an exciting development, Lord's Mark Industries has secured registration for its In-Vitro Diagnostic portfolio with the MHRA, significantly boosting market access. This follows the approval of their AI-enhanced Renalyx haemodialysis system in the UK. The firm aims for a December 2026 market launch for its IVD products, ahead of schedule, along with a planned January 2027 start for its pathology lab, highlighting its strong commitment to global healthcare integration.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hoce1DA
via IFTTT

Read More

Centre may seek legal view on licensing of sterile drugs

The government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Supreme Court decision that restricted the enforcement authority of central officials. A meeting of the drugs consultative committee underscored the essential requirement for specialized regulatory oversight for these sensitive products, aiming for uniform regulations. A dedicated sub-committee will evaluate the proposal's feasibility and gather legal insights before any definitive actions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/p6l2iYZ
via IFTTT

Read More

Ayush services sector supports 1.76 million livelihoods; women constitute 43% of the workforce

The Ayush services sector supports 1.76 million livelihoods in India and has a significant female workforce. Women's participation in organized segments, including hospitals, exceeds 50 percent in several areas. The sector has the potential to expand substantially, generating an estimated USD 216-318 billion by 2047. Ayurveda remains the largest individual system of revenue generation within the sector, contributing significantly.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zRjr0f8
via IFTTT

Read More

Wall Street’s $10 billion India hospital bet sparks a fight over bills

Wall Street has poured about $10 billion into Indian hospital chains over the past five years, with investors including Blackstone, KKR, TPG and General Atlantic betting on India’s huge shortage of hospital beds and rising demand for specialised care.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/W2kVamB
via IFTTT

Read More